Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
暂无分享,去创建一个
H. Waskin | A. Langston | I. Raad | P. Chandrasekar | M. Laverdière | N. Kartsonis | O. Cornely | S. Haider | A. Candoni | R. Duarte | M. van Iersel | D. Helfgott | J. L. Jiménez | N. Connelly | M. V. van Iersel